Ventyx Biosciences Appoints Allison J. Hulme, Ph.D. and Onaiza Cadoret-Manier to its Board of Directors
Dr. Allison Hulme currently serves as Chief Executive Officer, President and a board member of Aeovian Pharmaceuticals.
- Dr. Allison Hulme currently serves as Chief Executive Officer, President and a board member of Aeovian Pharmaceuticals.
- Prior to this, she served as Chief Operating Officer, Head of Research and Development and a board member at Sophiris Bio.
- Ms. Onaiza Cadoret-Manier currently serves as Executive Vice President, Chief Global Product Strategy and Operations officer at Ionis Pharmaceuticals.
- “Allison and Onaiza’s deep industry experience and commercialization expertise will be an invaluable addition to our board of directors.